In October 2026, I joined the Watt group as postdoctoral researcher. My work focuses on determinants of cardiovascular outcomes among long-term Hodgkin lymphoma survivors, including cancer treatment exposures, genetic susceptibility and cardiometabolic risk factors. Previously, my PhD research at the University of Exeter used UK Biobank data to investigate genetic and environmental determinants of haemochromatosis-related clinical outcomes.